The University of Wisconsin–Madison recognizes these extraordinary contributions of delivering over4 billion vaccines to people in 123 countries by awarding Krishna the Distinguished Alumni Award in 2011 and an honorary degree in 2022.
Tony Goldberg, a member of the GHI Advisory Committee, knows that most human diseases, like COVID-19, don’t start — or end — with our species. These diseases are really a part of our whole ecosystem, and that includes the animals we interact with.
The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab tests, according to a new study. However, lab tests also showed that the available antibody therapies — typically given intravenously in hospitals — are substantially less effective against omicron than against earlier variants of …
A new study confirms that, compared to earlier versions of the SARS-CoV-2 virus, the omicron variant causes less severe disease in mice and hamsters, which are reliable models for understanding COVID-19. The findings, previously available as a preprint and published following peer review today (Jan. 21) in the journal Nature, align with preliminary data from …
The National Institutes of Health is investing in three teams working to develop a vaccine against a broad range of coronaviruses. Among them is a research collaboration, the Pan-Coronavirus Vaccine consortium, led by UW–Madison School of Veterinary Medicine Professor of Pathobiological Sciences Yoshihiro Kawaoka, who is also a GHI Advisory Committee member.
GHI Advisory Committee Member Ajay Sethi discusses research on new variant, importance of patience and more.
GHI Advisory Committee Member Tony Goldberg discusses ongoing research into deer as a reservoir for the SARS-CoV-2 virus and more.
Experts on the front lines of pediatric vaccine development and public health, including GHI Associate Director James Conway, spoke during a Fearless Science Speaker Series webinar hosted by the Morgridge Institute on COVID-19 vaccines for children.
Bharat Biotech Covaxin COVID-19 vaccine approved by World Health Organization. Bharat Biotech founder and CEO Krishna Ella is a member of the GHI Board of Visitors.
Chen to headline a Crossroads of Ideas lecture with GHI Advisory Committee Members Dominique Brossard and Ajay Sethi.